Optimization of blood pressure measurement practices for pharmacodynamic analyses of tyrosine‐kinase inhibitors
Abstract Blood pressure measurements form a critical component of adverse event monitoring for tyrosine kinase inhibitors, but might also serve as a biomarker for dose titrations. This study explored the impact of various sources of within‐individual variation on blood pressure readings to improve m...
Saved in:
Main Authors: | Maddalena Centanni (Author), Abel Thijs (Author), Ingrid Desar (Author), Mats O. Karlsson (Author), Lena E. Friberg (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase Inhibitors
by: Maddalena Centanni, et al.
Published: (2020) -
Assessment of ibrutinib scheduling on leukocyte, lymph node size and blood pressure dynamics in chronic lymphocytic leukemia through pharmacokinetic‐pharmacodynamic models
by: Eman I. K. Ibrahim, et al.
Published: (2023) -
Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011) -
Mechanisms of resistance to EGFR tyrosine kinase inhibitors
by: Lihua Huang, et al.
Published: (2015) -
Transport of six tyrosine kinase inhibitors: active or passive?
by: Richard J. Honeywell, et al.
Published: (2016)